Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV- 10A1 retrovirus pseudotype

Human Gene Therapy

Volumn 11, Issue 7, 2000, Pages 1005-1014

  Uckert, Wolfgang ^a   Becker, Christian ^a   Gladow, Monika ^a   Klein, Dieter ^b   Kammertoens, Thomas ^a   Pedersen, Lene ^c   Blankenstein, Thomas ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CANCER; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; RETROVIRUS; T LYMPHOCYTE; VIRUS INFECTION;

CD8-POSITIVE T-LYMPHOCYTES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; RECEPTORS, VIRUS; RETROVIRIDAE; TRANSDUCTION, GENETIC;

ALOCASIA MACRORRHIZOS; AMPHOTROPIC MURINE LEUKEMIA VIRUS; FELIDAE; FELINE ENDOGENOUS VIRUS; GIBBON APE LEUKEMIA VIRUS; HYLOBATES SP.; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0034194324     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015310     Document Type: Article

References (36)

1. Abken, H., Hombach, A., Heuser, C., Sircar, R., Pohl, C., and Reinhold, U. (1997). Chimeric T cell receptors: Highly specific tools to target cytotoxic T lymphocytes to tumor cells. Cancer Treat. Rev. 23, 97-112.
2. Blaese, R.M., Culver, K.W., Miller, A.D., Carter, C.S., Fleischer, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., Greenblatt, J.J., Rosenberg, S.A., Klein, H., Berger, M., Mullen, C.A., Ramsey, W.J., Muul, L., Morgan, R.A., and Anderson, W.A. (1995). T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480.
3. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., and Bordignon, C. (1997). HSVtk gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
4. Boon, T., and Van Der Bruggen, P. (1996). Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725-729.
5. Bordignon, C., Notarangelo, L.D., Nobili, N., Ferrari, G., Casorati, G., Panina, P., Mazzolari, E., Maggioni, D., Rossi, C., Servida, P., Ugazio, A.G., and Mavilio, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475.
6. Bunnell, B.A., Mull, L.M., Bonahue, R.E., Blaese, R.M., and Morgan, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
7. Cormack, B.P., Valdivia, R.H., and Falkow, S. (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33-38.
8. Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., and Collins, M.K. (1995). High-titer packaging cells producing recombinant retrovirus resistant to human serum. J. Cirol. 69, 7430-7436.
9. Eshhar, Z., Wars, T., Gross, G., and Schindler, D.G. (1993). Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ and ζ subunits of the immunoglobin and T-cell receptors. Proc. Natl. Acad. Sci. U.S.A. 90, 720-724.
10. Fehse, B., Schade, U.M., Li, Z., Uhde, A., Koch, S., Goller, B., Rüger, R., Fehse, N., Stockschläder, M., and Zander, A. (1998). Highly efficient gene transfer with retroviral vectors into human T lymphocytes on fibronection. Br. J. Hematol. 102, 566-574.
11. Hege, K.M., and Roberts, M.R. (1996). T-cell gene therapy. Curr. Opin. Biotechnol. 7, 629-634.
12. Heslop, H.E., Ng, C.Y.C., Li, C., Smith, C.A., Loftin, S.K., Krance, R.A., Brenner, M.K., and Rooney, C.M. (1996). Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus specific T lymphocytes. Nature Med. 2, 551-555.
13. Kavanaugh, M.P., Miller, D.G., Zhang, W., Law, W., Kozak, S.L., Kabat, D., and Miller, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. U.S.A. 91, 7071-7075.
14. 0 from a human placental chorio-carcinoma cell line. J. Biol. Chem. 271, 18657-18661.
15. Klein, D., Indraccolo, S., Von Rombs, K., Amadori, A., Salmons, B., and Günzburg, W.H. (1997). Rapid identification of viable retrovirus-transduced cells using the green fluorescent protein as a marker. Gene Ther. 4, 1256-1260.
16. Kolb, H.J., Schattenberg, A., Goldman, J.M., Hartenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., and Niederwieser, D. (1995). Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 86, 2041-2050.
17. Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C., and Bordignon, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
18. Miller, A.D., and Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 989-990.
19. Miller, A.D., Garcia, J.V., Von Suhr, N., Lynch, C.M., Wilson, C., and Van Eiden, M.V. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
20. Miller, A.D. (1996). Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. U.S.A. 93, 11407-11413.
21. Miller, A.D., and Chen, F. (1996). Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70, 5564-5571.
22. Miller, D.G., and Miller, A.D. (1994). A family of retroviruses that utilize related phosphate transporters for cell entry. J. Virol. 68, 8270-8276.
23. Pollok, K., Van Der Loo, J.C.M., Cooper, R.J., Kennedy, L., and Williams, D.A. (1999). Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus. Hum. Gene Ther. 10, 2221-2236.
24. Porter, C.D., Collins, M.K.L., Tailor, C.S., Parkar, M.H., Cosset, F.-L., Weiss, R.A., and Takeuchi, Y. (1996). Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors. Hum. Gene Ther. 7, 913-919.
25. Rasko, J.E.J., Battini, J.-L., Gottschalk, R.J., Mazo, I., and Miller, A.D. (1999). The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc. Natl. Acad. Sci. U.S.A. 96, 2129-2134.
26. Riddell, R.S., and Greenberg, P.D. (1995). Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13, 545-586.
27. Riddell, R.S., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E., and Greenberg, P.D. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257, 238-241.
28. Riddell, R.S., Elliott, M., Lewinsohn, D.A., Gilbert, M.J., Wilson, L., Manley, S.A., Lupton, S.D., Overell, R.W., Reynolds, T.C., Corey, L., and Greenberg, P.D. (1996). T cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2, 216-223.
29. Riggs, J.L., McAllister, R.M., and Lenette, E.H. (1974). Immunofluorescent studies of RD-114 virus replication. J. Gen. Virol. 25, 21-29.
30. Tailor, C.S., Nouri, A., Zhao, Y., Takeuchi, Y., and Kabat, D. (1999). A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73, 4470-4474.
31. Uckert, W., Willimsky, G., Pedersen, F.S., Blankenstein, T., and Pedersen, L. (1998a). RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum. Gene Ther. 9, 2619-2627.
32. Uckert, W., Kammertöns, T., Haack, K., Qin, Z., Gebert, J., Schendel, D.J., and Blankenstein, T. (1998b). Double suicide gene transfer (cytosine deaminase and HSV-thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum. Gene Ther. 9, 855-865.
33. Uckert, W., Pedersen, L., and Günzburg, W. (2000). Green fluorescent protein retroviral vector: Generation of high-titer producer cells and virus supernatant. In Methods in Molecular Medicine, Vol. 35: Gene Therapy: Methods and Protocols. W. Walther and U. Stein, eds. (Humana Press, Totowa, NJ) pp. 271-281.
34. Von Laer, D., Thomsen, S., Vogt, B., Donath, M., Kruppa, J., Rein, A., Ostertag, W., and Stocking, C. (1998). Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cells. J. Virol. 72, 1424-1430.
35. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
36. Yee, C., Riddell, S.R., and Greenberg, P.D. (1997). Prospects for adoptive T cell therapy. Curr. Opin. Immunol. 9, 702-708.